Navigation Links
Nile Therapeutics Reports 2010 Fourth Quarter and Full Year Financial Results
Date:3/14/2011

lack of experience in developing and commercializing pharmaceutical products. Additional risks are described in greater detail in the reports Nile files with Securities and Exchange Commission, including those described under the caption "Risk Factors" in Item 1A of its Annual Report on Form 10-K for the year ended December 31, 2010 filed with the Securities and Exchange Commission on March 14, 2010. Nile is providing this information as of the date of this press release and does not undertake any obligation to update any forward-looking statements as a result of new information, future events or otherwise.

Nile Therapeutics, Inc.(A Development Stage Company)Statement of Operations(in thousands, except per share data)Three Months Ended
December 31,Twelve Months Ended
December 31,2010

20092010

2009Grant income$
-

$
-$
-

$
-Operating expenses:Research and development563

8894,081

4,467General and administrative480

6882,213

3,417 Total operating expenses 1,043

1,5776,294

7,884Loss from operations(1,043)

(1,577)(6,294)

(7,884)Basic and diluted operating loss per share(0.03)

(0.06)(0.20)

(0.31)Other income (expense)247

11262

11Net loss$  (796)

$ (1,566)$ (6,032)

$ (7,873)Basic and diluted loss per share$ (0.02)

$   (0.06)$   (0.19)

$   (0.31)Weighted-average common shares outstanding34,630

27,05932,168

25,467Summary Balance Sheet Data(in thousands)December 31,2010

2009Cash and cash equivalents$ 3,378

$ 3,176Total assets$ 3,666

$ 3,620Stockholders' equity$ 2,597

$ 2,982
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014  Lpath, Inc. (NASDAQ: LPTN ... announced today that it has entered into definitive ... stock and 3,605,042 unregistered warrants in a registered ... registered share of common stock and one unregistered ... stock will be $3.475.  The warrants have an ...
(Date:9/19/2014)... ORLANDO, Fla. , Sept. 19, 2014  The ... grow, with the publication of two papers this past ... Otolaryngology – Head and Neck Surgery , finds ... objective and subjective measures of sleep disordered breathing, leading ... the reduction in obstructive sleep apnea severity and improvement ...
(Date:9/19/2014)... , Sept. 19, 2014  Over 200 runners participated ... to Benefit the Radiation Oncology Institute (ROI), hosted by ... Golden Gate Park in San Francisco.  ... , CEO of Radiation Business Solutions, "but at ... raised over $70,000 for the ROI this year. This ...
Breaking Medicine Technology:Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3
(Date:9/20/2014)... 2014 (HealthDay News) -- The avian flu that killed ... be spread through respiratory drops and therefore poses a ... Although no human illnesses have been linked to ... Research hospital have discovered natural mutations to the avian ... through the air in droplets. Current seasonal flu ...
(Date:9/20/2014)... TX (PRWEB) September 20, 2014 ... Forecast and Market Analysis to 2023?. The asthma ... decade, as it has become saturated with relatively ... inhaled corticosteroids (ICSs), inhaled corticosteroids and long-acting beta-agonists ... facing increasing generic competition. However, the launch of ...
(Date:9/20/2014)... NC (PRWEB) September 20, 2014 The excitement is ... in Mount Airy, North Carolina. This year the Surry Arts ... draws people from around the country who are still fans of ... Show is a sitcom that aired on CBS from 1960 through ... best show in American television history. Mount Airy, North Carolina ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 Plumbing ... 3.1 out of 5, indicating a moderately favorable purchasing ... this score reflects current and future pricing trends that ... high prices. Other factors that negatively affect buyer power ... for construction and the moderate switching costs. Buyers benefit, ...
(Date:9/20/2014)... 2014 Final Cut Pro X Plugin ... of the Information theme for FCPX filmmakers. , “Fun, cool, ... the Information theme,” says Christina Austin, CEO of Pixel Film ... professional.” , Information features easy to use controls that give ... environment. Change the background color, color of each circle outline, ...
Breaking Medicine News(10 mins):Health News:Avian Flu In Harbor Seals Could Infect People 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 3Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 4Health News:Mayberry Days Parade Cars will be Provided by Mount Airy Toyota and Mount Airy Chrysler Dodge Jeep Ram 2Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 2Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 3Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 4Health News:Today Pixel Film Studios Announced the Release of the Information Theme for Final Cut Pro X 2
... YORK, March 19 Prescribing Reference, Inc. (PRI),and Medicos, ... have now downloaded eMPR, the desktop and mobile version ... in the United States,have relied on the print editions ... Now eMPR is providing the exact same drug,information on ...
... German . , Transport processes in the cells ... roads. Molecular motors, which are special protein molecules, act as ... it along microtubules, which are the roads of the cell. ... trucks and can only move as far as the beginning ...
... using stem cell transplants are advancing promising treatments for ... cord injury, and heart disease. Now, scientists think that ... from diabetes or cancer. However, important questions need answers: ... stem cells be used to provide insulin cells that ...
... market-leading provider,of software for the control, management and ... its interactions with the,media through the use of ... world,s leading pharmaceutical companies, is a,truly international company, ... its,corporate office in London and major Research & ...
... 19 Mirion Technologies, the,leading global provider of ... industry, will showcase two new products at the,10th ... from,March 25th - 28th., Mirion,s Health Physics ... Contamination Monitor. The TwoStep Exit monitor is a,new ...
... COLORADO SPRINGS, Colo., March 19 Thanks to ... Foundation (NSPF), Washington,State University researchers plan to create ... will be the world,s premiere center for aquatic ... a physician and research,professor in WSU,s College of ...
Cached Medicine News:Health News:eMPR Digital Drug Reference Reaches 50,000 Downloads and the Publisher Launches a Raffle for Healthcare Providers 2Health News:eMPR Digital Drug Reference Reaches 50,000 Downloads and the Publisher Launches a Raffle for Healthcare Providers 3Health News:Tug of war in the cells 2Health News:Tug of war in the cells 3Health News:Coming soon: Cell therapies for diabetes, cancer? 2Health News:Coming soon: Cell therapies for diabetes, cancer? 3Health News:Solcara Helps AstraZeneca Set International Benchmark for Global Media Relations 2Health News:Solcara Helps AstraZeneca Set International Benchmark for Global Media Relations 3Health News:Mirion Technologies to Showcase New Product Offerings for the Nuclear Industry During 10th Annual China International Nuclear Industry Exhibition 2Health News:Exploring the 'Aaah' ... $1 Million Grant Advances Aquatic Health Research 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: